Tolvaptan

Product NDC
0480-3313
11-digit product format
004803313
Labeler code
0480
Product ID
0480-3313_55f269ec-f4f3-48c0-a7ea-b5d8a97344d9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tolvaptan
Dosage form
KIT
Labeler
Teva Pharmaceuticals, Inc.
Application
ANDA216933
Marketing category
ANDA
Marketing start
2026-08-27
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A216933-001TOLVAPTANTOLVAPTAN15MGTABLET / ORALAB22026-07-21
A216933-002TOLVAPTANTOLVAPTAN30MGTABLET / ORALAB22026-07-21
A216933-003TOLVAPTANTOLVAPTAN45MGTABLET / ORALAB22026-07-21
A216933-004TOLVAPTANTOLVAPTAN60MGTABLET / ORALAB22026-07-21
A216933-005TOLVAPTANTOLVAPTAN90MGTABLET / ORALAB22026-07-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-productTE code
A216933-001AB2
A216933-002AB2
A216933-003AB2
A216933-004AB2
A216933-005AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A216933-001TOLVAPTAN15MGTABLET / ORALAB22026-07-2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-002TOLVAPTAN30MGTABLET / ORALAB22026-07-2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-003TOLVAPTAN45MGTABLET / ORALAB22026-07-2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-004TOLVAPTAN60MGTABLET / ORALAB22026-07-2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-005TOLVAPTAN90MGTABLET / ORALAB22026-07-2184e616aacf4f…
2026-08-18 06:07:402026-07A216933-001TOLVAPTAN15MGTABLET / ORALAB22026-07-21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-002TOLVAPTAN30MGTABLET / ORALAB22026-07-21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-003TOLVAPTAN45MGTABLET / ORALAB2026-07-21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-004TOLVAPTAN60MGTABLET / ORALAB22026-07-21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-005TOLVAPTAN90MGTABLET / ORALAB2026-07-21caaa826d4ba7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A216933-001AB2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-002AB2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-003AB2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-004AB2184e616aacf4f…
2026-09-14 22:38:342026-08A216933-005AB2184e616aacf4f…
2026-08-18 06:07:402026-07A216933-001AB21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-002AB21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-004AB21caaa826d4ba7…
2026-08-18 06:07:402026-07A216933-005AB1caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Tolvaptan
Listing expiration
2027-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 10 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2044359Internal RxNorm lookup
2044363Internal RxNorm lookup
2044367Internal RxNorm lookup
2044966Internal RxNorm lookup
2044968Internal RxNorm lookup
2044970Internal RxNorm lookup
2274813Internal RxNorm lookup
2274815Internal RxNorm lookup
2719335Internal RxNorm lookup
2719337Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
808a9a1f-2f58-4677-9127-e749ad007094Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TolvaptanTOLVAPTANTeva Pharmaceuticals, Inc.808a9a1f-2f58-4677-9127-e749ad0070942025-03-09Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216933
application number: ANDA216933
ndc (product): 0480-3313

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0480-3313-66004803313664 BLISTER PACK in 1 CARTON (0480-3313-66) / 1 KIT in 1 BLISTER PACK (0480-3313-14) * 7 TABLET in 1 BLISTER PACK (0480-4093-11) * 7 TABLET in 1 BLISTER PACK (0480-3266-11) 4 blister pack2026-08-27NoNoCurrent